Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Minimization trials

Because (4> ff S) is not in itself a variational expression, its unconstrained minimum value is not simply related to an eigenstate of the Hamiltonian Hv defined by v in Eq.(3), whereas Eq.(2) defines F[p only for such eigenstates. Any arbitrary trial function J —> can be expressed in the form + Aca with ca = 1. If the minimizing trial function in Eq.(3) were not an eigenfunction of Hv, then for some subset of trial functions, using the Brueckner-Brenig condition,... [Pg.75]

Tray area. Using an entrainment flooding correlation is the usual method of calculation, but short-cut methods (e.g., Ref. 10) are often adequate. However, to minimize trial and error, the author prefers to perform the preliminary estimate using the flooding correlation which will eventually be used, with some simplifying assumptions. In this example, the Kister and Haas correlation [Eq. (6.12)] will be used for the preliminary determination of tray area. Make the following simplifying assumptions ... [Pg.338]

For a minimized trial 1 < E A2 < (2n - 3)/(2n — 4). Thus for reasonably large trials, the gain in efficiency compared with randomized trials is negligible and may not offset the other losses (loss in blinding, inferential problems and so forth). [Pg.90]

Bias in minimization trials can be avoided when three conditions are met. First, those performing the clinical trial itself, i.e. administering test medications and measuring end-points, should be double-blind and unaware of which treatment the patient has received. Second, the independent coordinator need only allocate patients to anonymous groups A or B, and the study pharmacist need be the only person who knows which treatments these codes represent. Third, the criteria for which... [Pg.126]

If you don t know the key of a performance or a sampled media file, and you are sure it is short and doesn t contain any key changes, there are at least two ways you can determine the key of a loop with minimal trial-and-error stnmbling. Keep in mind that while the root note of a loop and the key of the loop are eqnivalent concepts, the root note does not need to be used in the loop. You could write an entire symphony in the key of D and never play the actual note D at any time. [Pg.199]

The representation of trial fiinctions as linear combinations of fixed basis fiinctions is perhaps the most connnon approach used in variational calculations optimization of the coefficients is often said to be an application of tire linear variational principle. Altliough some very accurate work on small atoms (notably helium and lithium) has been based on complicated trial functions with several nonlinear parameters, attempts to extend tliese calculations to larger atoms and molecules quickly runs into fonnidable difficulties (not the least of which is how to choose the fomi of the trial fiinction). Basis set expansions like that given by equation (A1.1.113) are much simpler to design, and the procedures required to obtain the coefficients that minimize are all easily carried out by computers. [Pg.38]

The denominator is included in equation (A 1.1.115) because it is impossible to ensure tliat the trial fiinction is nomialized for arbitrarily chosen coefficients c. In order to minimize the value of e for the trial fiinction... [Pg.38]

Perhaps the simplest examination done is the physical match. A small fragment of wood, plastic, or other material is recovered and fitted into a large piece found on the suspect or at the scene of the crime (39). Other examinations result ordy in demonstrating class characteristics (40). Such information may be used in a prosecution as circumstantial evidence in a trial. However, it is important that the forensic scientist neither inflate nor minimize (41,42) its importance. [Pg.487]

The first SRS-A antagonist, FPL-55712 (26) (149), was discovered before the stmctures of the leukotrienes were detemiined. Although this compound is relatively weak as an antagonist and suffers from a very short half-life in vivo, it played an important role both in leukotriene stmcture elucidation and as a model for later antagonists. In work stmcturaHy related to FPL-55712, LY-171883 was developed (27) (150). LY-171883 was evaluated in several clinical trials before development was stopped. Orally adrninistered, LY-171883 blocked slightly the response to aerosol LTD improved pulmonary function (FEV ) in mild asthmatics (151), decreased the sensitivity of asthmatics to cold air-induced bronchoconstriction (152), and significantly reduced the bronchoconstrictor response to inhaled antigen (153). However, in all these studies the beneficial effects were minimal. [Pg.445]

Motivation Unit tests require a substantial investment in time and resources to complete successfully. This is the case whether the test is a straightforward analysis of pump performance or a complex analysis of an integrated reactor and separation train. The uncertainties in the measurements, the likelihood that different underlying problems lead to the same symptoms, and the multiple interpretations of unit performance are barriers against accurate understanding of the unit operation. The goal of any unit test should be to maximize the success (i.e., to describe accurately unit performance) while minimizing the resources necessary to arrive at the description and the subsequent recommendations. The number of measurements and the number of trials should be selected so that they are minimized. [Pg.2562]

I [n). Then the norm of the residual vector is minimized in the subspace spanned by I and the new trial eigenstate is given by... [Pg.72]


See other pages where Minimization trials is mentioned: [Pg.75]    [Pg.76]    [Pg.109]    [Pg.109]    [Pg.111]    [Pg.111]    [Pg.173]    [Pg.89]    [Pg.146]    [Pg.78]    [Pg.125]    [Pg.127]    [Pg.228]    [Pg.75]    [Pg.76]    [Pg.109]    [Pg.109]    [Pg.111]    [Pg.111]    [Pg.173]    [Pg.89]    [Pg.146]    [Pg.78]    [Pg.125]    [Pg.127]    [Pg.228]    [Pg.37]    [Pg.37]    [Pg.38]    [Pg.2220]    [Pg.314]    [Pg.463]    [Pg.180]    [Pg.246]    [Pg.27]    [Pg.184]    [Pg.23]    [Pg.219]    [Pg.219]    [Pg.440]    [Pg.308]    [Pg.310]    [Pg.311]    [Pg.83]    [Pg.510]    [Pg.485]    [Pg.428]    [Pg.23]    [Pg.58]    [Pg.73]   
See also in sourсe #XX -- [ Pg.11 , Pg.109 ]




SEARCH



Methodology to minimize bias in open-label trials

© 2024 chempedia.info